Now that 2026 has just started, it makes sense to consider what we might expect as investors in the year ahead. There are some factors that make 2026 different and special, and that allows us to consider historical data from similar years inLong-time stock market investor focused on strategic buying opportunities with dividend and value stocks. This investment strategy has resulted in a near 5 star rating on Tipranks.com and over 9,000 followers on Seeking Alpha. Follow me on Twitter for my latest trading i ...

Group 1 - The article highlights the difficulty in finding worthwhile stocks in an overheated market, yet identifies strategic buying opportunities, particularly in dividend and value stocks [1] - The investment strategy employed has led to a near 5-star rating on Tipranks.com and a following of over 9,000 on Seeking Alpha, indicating a strong reputation in the investment community [1] - The focus is on purchasing select stocks that have been undervalued or beaten down in the current market conditions [1]

Summary of Key Points Core Viewpoint - The article reflects on the significant decline in Moderna's stock price since 2021, when shares were priced around $500, indicating a notable shift in market perception and valuation of the company [1]. Company Performance - In 2021, Moderna shares were approximately $500 each, meaning an investment of 100 shares would have cost about $50,000 [1]. Investment Strategy - The author emphasizes a long-term investment strategy focused on strategic buying opportunities, particularly in dividend and value stocks, which has garnered a high rating on investment platforms [1].